ILiAD's pertussis shot joins Trojan horse of childhood vaccines
ILiAD Biotechnologies successfully added its pertussis vaccine to a Trojan horse lineup of childhood vaccines in a phase 2b trial.
Stay updated with breaking news from Keith Rubin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ILiAD Biotechnologies successfully added its pertussis vaccine to a Trojan horse lineup of childhood vaccines in a phase 2b trial.
Return to the Kit Kat Club in 1929 Berlin Friday evening in Culbreth Theatre at the University of Virginia.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
The FDA has granted Fast Track designation to BPZE1 for active booster immunization against pertussis.
ILiAD Biotechnologies announces enrollment of the first participants in the SUPER Trial (Standing Up to PERtussis) the first study in school-age children of BPZE1, a live attenuated intranasal pertussis